If we have selected the wrong experience for you, please change it above.
Life Sciences & Health Care
In the Life Sciences & Health Care industry, it’s crucial for organisations to balance patient needs, market opportunities and policy compliance—all while innovating. Deloitte’s IndustryAdvantage approach combines industry insights, emerging technologies, and a powerful network of alliance partners to help turn ambition into measurable impact.
Where impact happens.
As increasing patient demands clash with outdated operations and clinical care models, the Life Sciences & Health Care industry is faced with reimagining how health is delivered, financed and experienced.
Deloitte’s IndustryAdvantage approach is designed to progress the evolution of health. Combining sector knowledge, advanced technologies, strategic alliances and regulatory insights, we accelerate the journey from scientific discovery to patient impact. This way, leaders can focus on the health of patients and communities.
The result? A health system that's more connected and responsive to patients and frees clinicians and researchers to focus their time on improving health outcomes.
Our thinking
Building coalitions for better health
This report explores how cross-sector, place-based coalitions align stakeholders, capabilities and resources to turn ambition into action, using NCD outcomes as a use case.
Navigating the GLP-1 boom
Welcome to the 16th edition of Measuring the return from pharmaceutical innovation. This year, the analysis shows an industry at an inflection point.
Deloitte at HLTH Europe
From digital health to biotech and from digital therapeutics to health care IT innovations, there’s a community and a conversation about it at HLTH Europe event.
Beyond borders: Japanese life sciences organisations evolving for global growth
Insights and learnings for Japanese life sciences organisations that are globalising to fulfil growth ambitions. Driven by domestic economic and industry-specific challenges, many Japan-headquartered life sciences organisations are looking at greater globalisation as a catalyst for growth and innovation. This report highlights this trend via executive interviews across Japanese life sciences (LS) organisations, non-Japanese LS organisations, and cross-industry Japanese organisations.
Life Sciences and Healthcare Predictions 2030
Welcome to the fourth of a series of life sciences and healthcare predictions reports, comprising ten predictions exploring how the world could look in 2030, what it might feel like for different stakeholders in the health ecosystem, the evidence today that informs our views of tomorrow and how AI technologies, specifically GenAI, might help to bring the future closer.
Future of Health Series
The Future of Health Series is a dynamic collection of webcasts designed to spark conversations and drive meaningful change across the health care landscape.
Empowering the health care workforce for a climate-resilient future
In this report, Project HOPE and Deloitte US have brought together frontline health care workers, programme leaders, health system advisors, policy and advocacy professionals, community leaders, and strategic relationships to collaborate on potential solutions for enhancing climate resilience.
Platform business models: Private equity opportunities in the life sciences and health care sector
Platform businesses are rewiring the traditional value chain. In nearly every industry, well-thought-out platform businesses typically beat traditional businesses because of superior unit economics and network effects.
Electronic Health Records Solution
Deloitte's Electronic Health Record (EHR) solution helps health systems execute digital transformation that shifts legacy models into modern best practices anchored on elevating the human experience.
Stories of Impact: Case Study
Read about how our firms are working with clients to combine solutions with action, bringing together deep industry knowledge with leading talent and innovative solutions.
Deloitte recognised as a Leader in Everest Group Life Sciences Smart Manufacturing Services PEAK Matrix® Assessment 2023
